PERSONALIS INC (PSNL) Stock News

Personalis to Participate at the TD Cowen's 45th Annual Health Care Conference

Goodyear Tire & Rubber Posts Upbeat Results, Joins Nu Skin, Pacific Biosciences of California, Airbnb, Roku And Other Big Stocks Moving Higher On Friday

Mentions: DKNG ABNB CAE UDMY ...

Personalis to Announce Fourth Quarter and Full Year 2024 Financial Results

Personalis to Participate at the BTIG Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference

Personalis Stock: A Deep Dive Into Analyst Perspectives (7 Ratings)

New Nature Medicine Publication Shows ctDNA Levels Linked to Recurrence Risk in Lung Cancer

Personalis Reports Preliminary Fourth Quarter and Full Year 2024 Revenue

Oncology Advancements Accelerate Amid Rising Early-Onset Cancer Diagnoses

/PRNewswire/ -- USA News Group News Commentary – The American Cancer Society has published its Advances in Oncology – 2024 Research Highlights, underscoring...

Mentions: ONCY CRDF TEM CKPT

PSNL Stock Earnings: Personalis Beats EPS, Beats Revenue for Q2 2024

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Personalis (NASDAQ:PSNL) just reported results for the second quarter of 2024.P...

Personalis Advances Business Strategy with Investment from Merck and Extends Collaboration with Moderna

Personalis and Tempus Expand Collaboration to Biopharma

Mentions: TEM

Personalis to Participate at Upcoming Investor Conferences

Personalis Reports Third Quarter 2024 Financial Results

Personalis to Present at the Stifel 2024 Healthcare Conference

Personalis to Announce Third Quarter 2024 Financial Results

ESMO 2024 Data Expands on Compelling Performance of Personalis NeXT Personal® MRD Test

Personalis to Participate at Upcoming Investor Conferences

Why Tempus AI Stock Skyrocketed Nearly 22% Today

It deepened its involvement in a client and peer.

Mentions: TEM

Personalis Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Personalis and Tempus Announce Expanded Collaboration

PSNL Stock Earnings: Personalis Beats EPS, Beats Revenue for Q2 2024

PSNL stock results show that Personalis beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.

Personalis Reports Second Quarter 2024 Financial Results

Myriad Genetics Reports Strong Second Quarter 2024 Financial Results, including 15% Revenue Growth Year-Over-Year; Raises 2024 Financial Guidance and Long-Term Revenue Growth Target to 12%

Mentions: MYGN GSK QGEN

Personalis to Participate at the 9th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference

Personalis to Announce Second Quarter 2024 Financial Results

Myriad Genetics and Personalis Cross-License Foundational MRD Intellectual Property to Broaden Patient Access to Testing

Mentions: MYGN